Nadroparin for prevention of thromboembolic events in cancer patients receiving chemotherapy: a randomized placebo-controlled double-blind study.

Pas encore traduit Pas encore traduit
Auteurs
Catégorie Primary study
JournalSupportive Care in Cancer
Year 2009

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: b54fa349f82bb1aaa931dceb784d378c930bcf11
First added on: Feb 23, 2021